Genetic-based Biomarkers and Next-Generation Sequencing (NGS)

Biomarkers have several uses in pharmaceutical R & D. With the recent introduction of high performance instrumentation, protein and gene arrays and bioinformatics, clinical decisions like Drug development and choosing type of treatment can be made efficiently. However, there is a lack of valid biomarkers to increase the drug development from pre-clinical through all levels of clinical studies. Biomarker in Drug Discovery can also lead to development of Personalized Medicines.

  • NGS for the discovery of Biomarkers
  • MicroRNA sequencing for the prediction of diseases
  • SNP as Biomarkers
  • Cytogenetic & Oxidative stress Biomarkers
  • Genetic-based Biomarkers and NGS in personalized care of Cancer

Related Conference of Genetic-based Biomarkers and Next-Generation Sequencing (NGS)

July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 16-17, 2024

9th World Conference on Breast and Cervical Cancer

London, UK
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France
November 25-26, 2024

7th International Conference on Anti-Cancer Drugs & Therapies

Vancouver, Canada
December 10-11, 2024

8th Global Meeting on Oncology and Radiology

Dubai, UAE

Genetic-based Biomarkers and Next-Generation Sequencing (NGS) Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in